Third, we used this LC–MS assay to determine that leptin deficiency and insulin resistance do not contribute to hyperoxaluria in ob/ob mice because leptin replacement or pioglitazone treatment did not affect urine oxalate excretion. This evidence concerns the gene LEP and Insulin resistance.